Form4insider filings, from the source

SEC Form 4 · accession 0001562180-18-001968

Sage Therapeutics, Inc. · SAGE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kimi Iguchi
Officer — CFO & Treasurer
Period of report
Apr 23, 2018
Accepted (ET)
Apr 25, 2018 · 5:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Apr 23, 2018S2,999$142.84D63,499D
Common StockF3Apr 23, 2018S4,700$143.90D58,799D
Common StockF4Apr 23, 2018S2,601$144.71D56,198D
Common StockF5Apr 23, 2018S700$145.58D55,498D
Common StockF6Apr 23, 2018S635$149.54D54,863D
Common StockF7Apr 23, 2018S500$150.68D54,363D
Common StockF8Apr 24, 2018S2,500$141.51D51,863D
Common StockF9Apr 24, 2018S900$142.50D50,963D
Common StockF10Apr 24, 2018S500$144.06D50,463D
Common StockF11Apr 24, 2018S600$145.10D49,863D
Common StockF12Apr 24, 2018S500$146.14D49,363D
Common StockF13Apr 25, 2018S7,818$140.38D41,545D
Common StockF14Apr 25, 2018S2,300$141.26D39,245D
Common StockF15Apr 25, 2018S900$142.69D38,345D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses